1. IMPORTANT NEWS: INCREASED ACCESS TO PRETOMANID/BPaL
Hope of a cure for individuals with XDR-TB.
WHO/Europe has launched a new online course to strengthen the capacity to diagnose drug-resistant tuberculosis (DR-TB) using molecular techniques. This free course, entitled “Drug-resistant tuberculosis: how to interpret rapid molecular test results”, is available on the OpenWHO platform and includes opportunities for participants throughout the world to seek expert advice for their diagnostic questions.
3. Korea upgrades guidelines for multidrug-resistant TB
Korean patients with multidrug-resistant tuberculosis (TB) will likely get faster and better treatment than now.